company

HEMO AS

5211 OS

Return on Equity
−27,03 %
Current Ratio
2,91
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue2 494 000
Net Income−133 000
Total Assets707 000
Total Equity492 000
Income (NOK)2022
Revenue2 494 000
Expenditure2 665 000
Operating Profit−171 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−171 000
Tax−38 000
Net Income−133 000
Balance (NOK)2022
Total Fixed Assets81 000
Total Current Assets626 000
Total Assets707 000
Total Retained Equity471 000
Total Equity492 000
Total Long-Term Debt0
Total Current Debt215 000
Total Equity and Debt707 000
Cash flow (NOK)2022
Sales Income2 494 000
Other Income0
Revenue2 494 000
Cost of Goods Sold1 312 000
Salary Costs1 009 000
Depreciation25 000
Impairment0
Expenditure2 665 000
Operating Profit−171 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−133 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets33 000
Real Eastate0
Machinery and Plant Facilities29 000
Fixtures19 000
Total Tangible Assets48 000
Total Fiancial Fixed Assets0
Total Fixed Assets81 000
Stock79 000
Total Investments0
Cash, Bank335 000
Total Current Assets626 000
Total Assets707 000
Total Equity492 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors11 000
Unpaid Taxes31 000
Dividends0
Other Current Debt173 000
Total Current Debt215 000
Total Equity and Debt707 000
Financial indicators2022
Return on Equity−27,03 %
Debt-to-Equity Ratio0
Operating Profit Margin−6,86 %
Current Ratio2,91
Quick Ratio4,6
Equity Ratio0,7
Gross Profit Margin47,39 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English